‘Godzilla’ of weight-loss drugs could provide other important health benefits

Though not yet approved by any regulatory agency, Retatrutide could help improve blood sugar levels and reduce inflammation

一項大型三期試驗顯示，同時作用於GLP-1、GIP和胰高血糖素受體的retatrutide最高可使肥胖合並2型糖尿病者平均減重18.8%，並改善血糖、血壓、血脂與炎症指標。該藥尚未獲批，常見不良反應為胃腸道症狀，試驗由生產商禮來資助。